Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 21, 2019; 25(31): 4481-4492
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4481
Published online Aug 21, 2019. doi: 10.3748/wjg.v25.i31.4481
Wild type gene | Primers, 5'-3' | Annealing temperature (°C) |
NOD2 (2104C) R702W | CCAGACATCTGAGAAGGCCCTGCTC | 65 |
rs2066844 | GGCGCCAGGCCTGTGCCCGCTGGTG | |
NOD2 (2722G) | CTCTTTTGGCCTTTTCAGATTCTGG | 52 |
rs2066845 | GCAACAGAGTGGGTGACGAGGGGGC | |
NOD2 (3020T) 3020insC | GGGGCAGAAGCCCTCCTGCAGGCCC | 54 |
rs2066847 | TTGAAAGGAATGACACCATCCTGGA |
- Citation: Hoffmann P, Krisam J, Wehling C, Kloeters-Plachky P, Leopold Y, Belling N, Gauss A. Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease. World J Gastroenterol 2019; 25(31): 4481-4492
- URL: https://www.wjgnet.com/1007-9327/full/v25/i31/4481.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i31.4481